Related Articles
Insulin restores UCP3 activity and decreases energy surfeit to alleviate lipotoxicity in skeletal muscle
AMPK and SREBP-1c mediate the anti-adipogenic effect of β-hydroxyisovalerylshikonin
SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease
Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice
Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway